Advances in Prognostic Methylation Biomarkers for Prostate Cancer

SIMPLE SUMMARY: Prostate cancer is a major cause of cancer-related death in men worldwide. There is an urgent clinical need for improved prognostic biomarkers to better predict the likely outcome and course of the disease and thus inform the clinical management of these patients. Currently, clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Dilys, Clark, Susan, Stirzaker, Clare, Pidsley, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602626/
https://www.ncbi.nlm.nih.gov/pubmed/33076494
http://dx.doi.org/10.3390/cancers12102993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602626/
https://www.ncbi.nlm.nih.gov/pubmed/33076494
http://dx.doi.org/10.3390/cancers12102993

Ejemplares similares